PDCD1 and nasopharyngeal carcinoma: Given the fact that the radiographic evaluation was difficult and inappropriate to be conducted so early and frequently in clinical practice, EBV assessment proved to be a convenient method for predicting the clinical efficacy of NPC patients receiving anti-PD-1 immunotherapy prior to radiologic review.